10 Results for "

GL-3

" in MedChemExpress (MCE) Product Catalog:
Products (10)

10 Results for "GL-3" in MCE Product Catalog:

Cat. No.: HY-N6873
CAS No.: 60037-39-0
GL3, the major component of O. fragrans seeds, is a derivative based on both phenylethanoid and methyloleoside .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-16743
CAS No.: 1401090-53-6
Synonyms: VenGLustat; SAR402671; GZ402671
Research Areas:  

Metabolic Disease

Ibiglustat (Venglustat) is an orally active, brain-penetrant glucosylceramide synthase (GCS) inhibitor. Ibiglustat can be used for the research of Gaucher disease type 3, Parkinson's disease associated with GBA mutations, Fabry disease, GM2 gangliosidosis, and autosomal dominant polycystic kidney disease .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-16743A
CAS No.: 1629063-78-0
Synonyms: VenGLustat (L-Malic acid); SAR402671 (L-Malic acid); GZ402671 (L-Malic acid)
Research Areas:  

Metabolic Disease

Ibiglustat (Venglustat) L-Malic acid is an orally active, brain-penetrant glucosylceramide synthase (GCS) inhibitor. Ibiglustat L-Malic acid can be used for the research of Gaucher disease type 3, Parkinson's disease associated with GBA mutations, Fabry disease, GM2 gangliosidosis, and autosomal dominant polycystic kidney disease .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-16743B
CAS No.: 1629063-80-4
Synonyms: VenGLustat succinate; SAR402671 succinate; GZ402671 succinate
Research Areas:  

Neurological Disease

Ibiglustat (Venglustat) succinate is an orally active, brain-penetrant glucosylceramide synthase (GCS) inhibitor. Ibiglustat succinate can be used for the research of Gaucher disease type 3, Parkinson's disease associated with GBA mutations, Fabry disease, GM2 gangliosidosis, and autosomal dominant polycystic kidney disease .
loading...
    loading...
Cat. No.: HY-N12408
CAS No.: 126550-86-5
Synonyms: Lyso-Gb3; Lyso-GL3
Category:  

Animals Lipids

Target:  

Calcium Channel

Globotriaosylsphingosine (Lyso-Gb3) inhibits the growth of fibroblasts, as well as their differentiation into myofibroblasts, and collagen expression. Globotriaosylsphingosine can be used for Fabry disease research .
loading...
    loading...
Cat. No.: HY-178968
Target:  

VEGFR

Research Areas:  

Cancer

VEGFR-2-IN-76 (Compound GL-3) is a potent VEGFR-2 inhibitor with an IC50 value of 5.44 μM. VEGFR-2-IN-76 can be used for cancer research .
loading...
    loading...
Cat. No.: HY-RS12838
Research Areas:  

Others

SH3GL3 Human Pre-designed siRNA Set A contains three designed siRNAs for SH3GL3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-16743C
CAS No.: 1629063-79-1
Synonyms: VenGLustat hydrochloride; SAR402671 hydrochloride; GZ402671 hydrochloride
Research Areas:  

Metabolic Disease

Ibiglustat hydrochloride is an orally active, brain-penetrant glucosylceramide synthase (GCS) inhibitor. Ibiglustat hydrochloride can be used for the research of Gaucher disease type 3, Parkinson's disease associated with GBA mutations, Fabry disease, GM2 gangliosidosis, and autosomal dominant polycystic kidney disease .
loading...
    loading...
Cat. No.: HY-RS21932
Research Areas:  

Others

Sh3gl3 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Sh3gl3 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-RS28448
Research Areas:  

Others

Sh3gl3 Rat Pre-designed siRNA Set A contains three designed siRNAs for Sh3gl3 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.
loading...
    loading...